Jens M. Kelm

Co-Founder & CEO at PreComb Therapeutics AG

Jens M. Kelm is among the pioneers and initial developers of 3D microtissue culture technology. He was founder, president and CSO of InSphero AG, commercializing one of the first physiological 3D models, assays and screening concepts. He is a co-founder of the Swiss competence center for 3D cell culture technologies (TEDD) and member of the steering committee of the 3D cell culture conference series 3DCC organized by the DECHEMA. Jens has published more than 50 publications and 11 Patents in the field. He holds a PhD in Biotechnology from the ETH Zürich.

Links

Previous companies

Universitätsspital Zürich logo
InSphero logo
University of Zurich logo

Timeline

  • Co-Founder & CEO

    Current role